Published in Neuro Oncol on June 07, 2013
Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling. Oncogene (2014) 0.83
Pathway analysis for drug repositioning based on public database mining. J Chem Inf Model (2014) 0.80
Polymerase I and transcript release factor acts as an essential modulator of glioblastoma chemoresistance. PLoS One (2014) 0.79
Biomarkers for glioma immunotherapy: the next generation. J Neurooncol (2015) 0.78
A Numerical Handling of the Boundary Conditions Imposed by the Skull on an Inhomogeneous Diffusion-Reaction Model of Glioblastoma Invasion Into the Brain: Clinical Validation Aspects. Cancer Inform (2017) 0.75
Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells. J Ovarian Res (2017) 0.75
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell (2006) 21.66
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med (2005) 15.42
Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell (2011) 6.43
An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg (2011) 6.32
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell (2012) 4.47
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A (2008) 4.14
Phase II trial of gefitinib in recurrent glioblastoma. J Clin Oncol (2003) 3.83
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol (2010) 3.67
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol (2011) 3.58
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A (2011) 3.48
The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res (2009) 3.42
Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery (2008) 2.33
The role of myosin II in glioma invasion of the brain. Mol Biol Cell (2008) 2.20
Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. Cancer Res (2009) 1.88
Tracking in cell and developmental biology. Semin Cell Dev Biol (2009) 1.77
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Res (2011) 1.69
The promise of patient-derived xenografts: the best laid plans of mice and men. Clin Cancer Res (2012) 1.63
Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux. J Pharmacol Exp Ther (2010) 1.57
Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys (1992) 1.54
Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res (2003) 1.53
Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma. Clin Cancer Res (2005) 1.52
Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial. Mol Cancer Ther (2011) 1.39
Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci (2008) 1.38
Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. Mol Biol Cell (2008) 1.27
PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia (2009) 1.24
Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2. Clin Cancer Res (2008) 1.24
Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration. J Cell Biol (2001) 1.22
Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma. Clin Cancer Res (2009) 1.18
Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis. Proc Natl Acad Sci U S A (2012) 1.08
Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology. Oncogene (2011) 1.07
Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysis. J Neurosurg (2002) 1.06
Gefitinib concentrations in human glioblastoma tissue. J Neurooncol (2006) 1.06
Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer (2004) 1.05
Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Mol Biol Cell (2012) 0.97
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074. Int J Radiat Oncol Biol Phys (2010) 0.95
Dynamic determination of human glioma invasion in vitro. J Neurosurg (1998) 0.80
Malignant astrocytoma cell attachment and migration to various matrix proteins is differentially sensitive to phosphoinositide 3-OH kinase inhibitors. J Cell Biochem (1999) 0.77
Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature (2003) 8.38
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature (2009) 5.48
Beta-catenin activation is necessary and sufficient to specify the dorsal dermal fate in the mouse. Dev Biol (2006) 3.17
The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet (2013) 2.89
A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science (2013) 2.86
Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci (2006) 2.43
Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci (2004) 2.35
Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery (2008) 2.33
The coiled-coil domain containing protein CCDC40 is essential for motile cilia function and left-right axis formation. Nat Genet (2010) 2.25
The role of myosin II in glioma invasion of the brain. Mol Biol Cell (2008) 2.20
RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis. J Neurosci (2006) 2.08
p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell (2006) 2.06
Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia (2006) 1.83
Survey of MicroRNA expression in pediatric brain tumors. Pediatr Blood Cancer (2010) 1.82
Microphysiology of epileptiform activity in human neocortex. J Clin Neurophysiol (2008) 1.78
Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS One (2011) 1.77
Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family. Am J Hum Genet (2004) 1.72
BMP signaling patterns the dorsal and intermediate neural tube via regulation of homeobox and helix-loop-helix transcription factors. Development (2002) 1.69
Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity. Mol Cancer Ther (2010) 1.69
Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry. Pediatr Blood Cancer (2012) 1.57
Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol (2009) 1.56
Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomas. J Neurosurg Pediatr (2012) 1.50
Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol Biol Cell (2006) 1.50
Grainyhead-like 2 regulates neural tube closure and adhesion molecule expression during neural fold fusion. Dev Biol (2011) 1.45
Patterns of care for craniopharyngioma: survey of members of the american association of neurological surgeons. Pediatr Neurosurg (2014) 1.41
Epithelioid pituicytoma. World Neurosurg (2011) 1.39
The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. Blood (2007) 1.38
Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci (2008) 1.38
MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer (2007) 1.37
Using genomewide mutagenesis screens to identify the genes required for neural tube closure in the mouse. Birth Defects Res A Clin Mol Teratol (2005) 1.30
Visualization of cartilage formation: insight into cellular properties of skeletal progenitors and chondrodysplasia syndromes. Dev Cell (2007) 1.29
Dynamic imaging of mammalian neural tube closure. Dev Biol (2010) 1.29
Coordinate regulation of neural tube patterning and proliferation by TGFbeta and WNT activity. Dev Biol (2004) 1.28
Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology (2000) 1.28
Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol (2013) 1.23
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res (2011) 1.22
Phactr4 regulates neural tube and optic fissure closure by controlling PP1-, Rb-, and E2F1-regulated cell-cycle progression. Dev Cell (2007) 1.21
Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny. Neurosurgery (2010) 1.19
Primitive neuroectodermal tumors of the spine: a comprehensive review with illustrative clinical cases. Neurosurg Focus (2011) 1.18
In toto live imaging of mouse morphogenesis and new insights into neural tube closure. Development (2012) 1.16
A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PLoS One (2012) 1.15
Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines. Pediatr Blood Cancer (2010) 1.15
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery (2011) 1.14
Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation. Glia (2010) 1.14
Gli3 and Plzf cooperate in proximal limb patterning at early stages of limb development. Nature (2005) 1.12
Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunol (2009) 1.11
Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells. BMC Cancer (2012) 1.10
Phactr4 regulates directional migration of enteric neural crest through PP1, integrin signaling, and cofilin activity. Genes Dev (2012) 1.09
Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells. Neuro Oncol (2012) 1.09
Immune gene and cell enrichment is associated with a good prognosis in ependymoma. J Immunol (2009) 1.09
Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys (2009) 1.06
The Hectd1 ubiquitin ligase is required for development of the head mesenchyme and neural tube closure. Dev Biol (2007) 1.06
Folic acid supplementation can adversely affect murine neural tube closure and embryonic survival. Hum Mol Genet (2011) 1.05
PARP1 expression in pediatric central nervous system tumors. Pediatr Blood Cancer (2009) 1.04
The ubiquitin ligase mLin41 temporally promotes neural progenitor cell maintenance through FGF signaling. Genes Dev (2012) 1.04
Tissue morphogenesis and vascular stability require the Frem2 protein, product of the mouse myelencephalic blebs gene. Proc Natl Acad Sci U S A (2005) 1.03
A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol (2010) 1.02
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2010) 1.02
The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn (2012) 1.02
Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget (2014) 1.02
Unique molecular characteristics of radiation-induced glioblastoma. J Neuropathol Exp Neurol (2007) 1.02
Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant (2009) 1.01
Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma. J Immunol (2008) 1.01
Targeting the enhancer of zeste homologue 2 in medulloblastoma. Int J Cancer (2012) 1.01
Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma. Acta Neuropathol (2013) 1.01
Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol (2003) 1.00
High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro Oncol (2011) 1.00
Tumor-associated macrophages in glioma: friend or foe? J Oncol (2013) 1.00
EGF signaling patterns the feather array by promoting the interbud fate. Dev Cell (2003) 0.99
Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion. Endocrinology (2006) 0.99
Genetic, epigenetic, and environmental contributions to neural tube closure. Annu Rev Genet (2014) 0.99
Mechanisms of tissue fusion during development. Development (2012) 0.99
Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors. Brain Pathol (2009) 0.98
Pilomyxoid astrocytoma: neuroimaging with clinicopathologic correlates in 4 cases followed over time. J Pediatr Hematol Oncol (2007) 0.98
Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol (2001) 0.97
Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Mol Biol Cell (2012) 0.97
MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem (2012) 0.96
Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2012) 0.96
Intracranial multimodal monitoring for acute brain injury: a single institution review of current practices. Neurocrit Care (2010) 0.96
Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas. Neurosurgery (2006) 0.95
Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors. J Immunol (2012) 0.95
The iron exporter ferroportin 1 is essential for development of the mouse embryo, forebrain patterning and neural tube closure. Development (2010) 0.95
Plasmid-based short-hairpin RNA interference in the chicken embryo. Genesis (2004) 0.94
Cell polarity pathways converge and extend to regulate neural tube closure. Trends Cell Biol (2003) 0.94
Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift? Neuro Oncol (2011) 0.94
Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells. J Neurooncol (2012) 0.93
Characterization of distinct immunophenotypes across pediatric brain tumor types. J Immunol (2013) 0.92
Unique molecular characteristics of pediatric myxopapillary ependymoma. Brain Pathol (2009) 0.92
Aurora kinase A as a rational target for therapy in glioblastoma. J Neurosurg Pediatr (2010) 0.92
Colorado surveillance program for chronic wasting disease transmission to humans: lessons from 2 highly suspicious but negative cases. Arch Neurol (2007) 0.92
E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation. J Neurosci (2014) 0.92
Multiparametric image analysis of lung-branching morphogenesis. Dev Dyn (2013) 0.92
Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma. J Neuropathol Exp Neurol (2006) 0.91